The Helsinki Collegium for Advanced Studies is an independent institute of advanced study within the University of Helsinki. It provides a top-class, international research environment for scholars in ...

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease. Blenrep (belantamab mafodotin) has been approved in ...